Omnicell (OMCL)
Nasdaq Market Closed
Omnicell, Inc. provides automation, software, and analytics solutions that help healthcare organisations manage medications more safely and efficiently. The company’s technology is used by hospitals, health systems, pharmacies, and other care providers to support medication dispensing, inventory control, adherence programmes, and pharmacy operations. Its products are designed to reduce manual work, limit medication errors, improve visibility across the drug supply chain, and help clinical staff spend more time on patient care.
Omnicell’s portfolio includes automated dispensing cabinets, central pharmacy automation, medication packaging systems, controlled substance management tools, and cloud-based software services. The company also offers advanced services and analytics that help providers optimise medication use and pharmacy workflows. These solutions are relevant across inpatient, outpatient, and long-term care environments, where medication management can be complex, labour-intensive, and financially significant.
The company generates most of its revenue in the United States, where health systems face continuing pressure to improve safety, control costs, and deal with staffing constraints. Omnicell’s market opportunity is shaped by the ongoing digitisation of healthcare operations and the need for more integrated medication management. Its performance depends on capital spending by healthcare providers, recurring software and service revenue, product reliability, and the ability to deliver measurable operational and clinical benefits. Within the healthcare technology sector, Omnicell is distinctive for its focus on pharmacy and nursing workflows rather than broad electronic medical records or general hospital administration.
Last updated
- Market Cap
- 1.75B
- P/E
- 85.49
- P/FCF
- 14.71
- P/S
- 1.43
- Enterprise Value
- 1.68B
- Sector
- Information Technology
- Industry
- Technology Hardware, Storage & Peripherals
- Address
- 4220 NORTH FREEWAY, FORT WORTH, TX, 76137
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 1.75B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 1.68B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 85.49
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.39
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 1.43
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 15.09
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 1.37
- EPS
- 0.45
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 14.71
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 11.21
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 118.77M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 1.63%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 1.02%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.13
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 1.5
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.29
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.5
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 600.43K
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 38.41
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 309.88M | 313.98M | 310.63M | 290.56M | 269.67M |
| Gross profit | 140.36M | 130.33M | 134.5M | 127.68M | 110.94M |
| Operating income | 16.85M | 415K | 8.24M | 8.12M | -11.62M |
| EBITDA | 35.43M | 20.23M | 27.65M | 27.71M | 8.38M |
| Net income | 11.36M | -2.03M | 5.46M | 5.64M | -7.02M |
| Basic EPS | 0.25 | -0.05 | 0.12 | 0.12 | -0.15 |
| Diluted EPS | 0.25 | -0.05 | 0.12 | 0.12 | -0.15 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 2B | 1.97B | 1.95B | 2.15B | 2.15B |
| Total liabilities | 747.48M | 742.91M | 727.7M | 881.88M | 894.37M |
| Total equity | 1.26B | 1.23B | 1.22B | 1.26B | 1.26B |
| Cash & equivalents | 239.22M | 196.52M | 180.05M | 399M | 386.83M |
| Current assets | 722.3M | 680.07M | 659.62M | 844.78M | 839.67M |
| Current liabilities | 483.05M | 476.61M | 456.59M | 594.39M | 607.53M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 54.5M | 30.35M | 28.27M | 42.76M | 25.92M |
| Investing cash flow | -15.87M | -14.42M | -14.28M | -15.92M | -15.74M |
| Financing cash flow | 2.39M | 9.1M | -219.98M | -11.47M | 4.04M |
| Change in cash | 39.93M | 25.58M | -206.05M | 17.1M | 15.79M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| form 4 | Form 4 — PARRISH MARK W | View Filing | |
| form 4 | Form 4 — Seim Robin Gene | View Filing | |
| form 4 | Form 4 — Bauer Joanne B | View Filing | |
| form 4 | Form 4 — Bousa Edward Peter | View Filing | |
| form 4 | Form 4 — Garrett Mary | View Filing | |
| form 4 | Form 4 — Voynick Eileen J. | View Filing | |
| form 4 | Form 4 — Scott Bruce E | View Filing | |
| form 4 | Form 4 — Ghoshal Kaushik | View Filing | |
| edgar index | SD — OMNICELL, INC. | View Filing | |
| edgar index | 8-K — OMNICELL, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 144 — OMNICELL, INC. | View Filing | |
| edgar index | 144 — OMNICELL, INC. | View Filing | |
| form 4 | Form 4 — Manley Corey J | View Filing | |
| form 4 | Form 4 — Njoku Nnamdi | View Filing | |
| edgar index | SCHEDULE 13G — OMNICELL, INC. | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — NUTT BRIAN H. | View Filing | |
| form 4 | Form 4 — Manley Corey J | View Filing | |
| form 4 | Form 4 — Njoku Nnamdi | View Filing | |
| edgar index | 10-Q — OMNICELL, INC. | View Filing | |
| edgar index | SCHEDULE 13G — OMNICELL, INC. | View Filing | |
| edgar index | 8-K — OMNICELL, INC. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — OMNICELL, INC. | View Filing | |
| edgar index | ARS — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | PRE 14A — OMNICELL, INC. | View Filing | |
| edgar index | SCHEDULE 13G — OMNICELL, INC. | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — Radford Harlan Baird | View Filing | |
| form 4 | Form 4 — NUTT BRIAN H. | View Filing | |
| form 4 | Form 4 — Manley Corey J | View Filing | |
| form 4 | Form 4 — Njoku Nnamdi | View Filing | |
| edgar index | SCHEDULE 13G/A — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 144 — OMNICELL, INC. | View Filing | |
| form 4 | Form 4 — Manley Corey J | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — LIPPS RANDALL A | View Filing | |
| form 4 | Form 4 — Manley Corey J | View Filing | |
| form 4 | Form 4 — Manley Corey J | View Filing | |
| form 4 | Form 4 — Njoku Nnamdi | View Filing | |
| form 4 | Form 4 — Njoku Nnamdi | View Filing | |
| edgar index | 10-K — OMNICELL, INC. | View Filing | |
| ten k section | 10-K — business | View Filing | |
| ten k section | 10-K — mda | View Filing | |
| ten k section | 10-K — risk_factors | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing | |
| edgar index | 4 — OMNICELL, INC. | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free